Process development is the work of designing, testing, and refining a manufacturing method so it reliably produces a product that meets quality standards every time. While the term applies across industries, it’s most commonly associated with pharmaceuticals, biotechnology, and food manufacturing, where getting the process wrong can mean a product that’s ineffective, unsafe, or too expensive to make. The goal is straightforward: figure out the exact combination of steps, conditions, and materials needed to go from a lab-scale idea to full commercial production.
What Process Development Actually Involves
At its core, process development means determining the inputs (raw materials, temperatures, timing, equipment settings) required to consistently produce an output that meets design requirements. Engineers run experiments to reveal the relationship between those inputs and the properties of the final product, including things like purity, potency, stability, and safety. The result is a defined sequence of steps, each with specific parameters, that together form a repeatable manufacturing method.
In pharmaceuticals, for example, the end product must meet strict quality attributes: identity (is it the right molecule?), purity (are contaminants below safe thresholds?), potency (does it work at the intended strength?), and content uniformity (is every tablet or vial consistent?). Process development is how manufacturers figure out the recipe and procedure to hit all those targets simultaneously.
The Major Phases
Process development typically moves through three broad stages, each with distinct goals.
Lab-scale discovery. Engineers and scientists start small, running bench-level experiments to identify which biological systems, chemical reactions, or manufacturing methods can produce the target product. At this stage, the focus is on proving feasibility: can you make the thing at all, and what conditions seem to work best?
Optimization and pilot scale. Once a basic method exists, teams run structured experiments to compare different conditions and narrow in on the best combination of steps, equipment, and settings. This is where financial feasibility enters the picture. A process that works beautifully in a flask but costs ten times too much at scale isn’t useful. Engineers perform comparative analysis between experimental conditions to make informed decisions about the order of operations and manufacturing methods.
Scale-up to commercial manufacturing. The final phase involves translating a proven lab or pilot process into full production. This is rarely as simple as multiplying everything by a larger number. Maintaining product quality while scaling from laboratory operations to industrial-scale equipment requires careful management, because physical factors like heat transfer, mixing, and flow behavior change when equipment gets bigger.
Upstream and Downstream Operations
In biotech and pharmaceutical manufacturing, the process splits into two halves. Upstream operations cover everything involved in producing the active material. In a biologic drug, that means growing cells, selecting the right culture conditions, and harvesting the raw product. In enzyme-based manufacturing, upstream work includes expressing the protein of interest in cells and stabilizing the biological catalyst for use.
Downstream operations handle everything after production: recovering, separating, and purifying the product to meet quality specifications. Common downstream steps include filtration (removing particles or concentrating solutions), chromatography (separating molecules based on their physical or chemical properties), crystallization, liquid-liquid extraction, and distillation. Each of these steps must be developed and optimized individually, then connected into a sequence that delivers a final product meeting all quality targets.
Getting the handoff between upstream and downstream right is one of the trickier parts of process development. A change in how cells are grown can alter the impurity profile downstream, forcing adjustments to purification steps that were already working.
How Quality Gets Built Into the Process
Modern process development follows a framework called Quality by Design, or QbD, which flips the old approach of testing quality into a finished product. Instead, quality is engineered into the process from the start. The framework has five core elements.
- Quality target product profile (QTPP): A predefined description of what the final product should look like, including its critical quality attributes.
- Critical quality attributes (CQAs): The specific physical, chemical, or biological properties that must fall within acceptable ranges. These can include things like degradation products, moisture content, drug release rate, and microbial limits.
- Critical material attributes (CMAs): Properties of the raw materials that affect the final product.
- Critical process parameters (CPPs): The specific process settings (temperature, pressure, pH, mixing speed, time) that directly influence whether CQAs are met.
- Control strategy: Specifications and controls for every step of manufacturing, from raw materials through finished product.
The practical value of QbD is that it forces teams to understand why their process works, not just that it works. By mapping the relationships between CPPs, CMAs, and CQAs, manufacturers can predict how changes will affect the product and set meaningful control limits rather than arbitrary ones.
Design of Experiments: Finding Optimal Conditions Faster
One of the most important tools in process development is Design of Experiments, or DoE. The traditional approach to optimization is changing one factor at a time: adjust the temperature, see what happens, then adjust the pH, see what happens. This is slow and misses interactions between variables. If temperature and pH together affect product quality in a way that neither does alone, a one-factor-at-a-time approach will never find that.
DoE solves this by testing multiple factors simultaneously in a structured pattern. A relatively small number of experiments can reveal not just which factors matter, but how they interact. The result is a mathematical model that predicts the best combination of factor levels to maximize yield, purity, or whatever outcome you’re optimizing. For complex processes with many variables, DoE can find optimal conditions dramatically faster than the trial-and-error alternative.
Scale-Up vs. Scale-Out
When a process is ready for higher production volumes, there are two fundamentally different strategies. Scale-up means moving to larger, higher-throughput equipment while keeping the same basic process concept. You replace a small bioreactor with a much bigger one, or swap a lab-scale mixer for an industrial version. The challenge is that heat generation, heat transfer, and mechanical energy don’t always scale proportionally. Larger systems can develop higher internal temperatures or different mixing patterns, which may alter product quality in unexpected ways.
Scale-out takes the opposite approach: instead of making the machine bigger, you replicate the proven process across multiple identical units or extend production run times. Because each unit operates at the same scale where the process was originally developed, factors like mixing behavior and residence time stay consistent. This is particularly valuable for processes that are sensitive to equipment geometry, such as certain extrusion-based pharmaceutical methods where even small changes in heat or mechanical energy can affect the product.
Neither strategy is universally better. Scale-up is often more space-efficient and requires less equipment, while scale-out offers more predictable quality and easier troubleshooting since each unit runs at a well-characterized scale.
Real-Time Monitoring and Process Analytics
Modern process development increasingly relies on real-time monitoring rather than end-of-batch testing. The FDA’s Process Analytical Technology (PAT) framework encourages manufacturers to use sensor-based measurements and data analysis tools to monitor quality during production, not just after it. Sensors embedded in equipment can generate continuous data streams that reveal process signatures: patterns related to the underlying steps or transformations happening in real time.
These signatures allow manufacturers to detect problems as they develop, adjust process conditions on the fly, and determine when a step has reached its endpoint rather than running for a fixed, arbitrary time. The data tools that make this possible include multivariate statistical process control, response surface modeling, and pattern recognition software, all of which can handle the large volumes of data that process analyzers produce.
Regulatory Requirements
For pharmaceutical and biotech products, process development feeds directly into regulatory submissions. The Chemistry, Manufacturing, and Controls (CMC) section of a regulatory filing must describe the composition, manufacture, and control of both the drug substance and the finished drug product. Regulators need sufficient information to confirm the identification, quality, purity, and strength of the product.
For early-stage clinical trials, the emphasis is on controlling raw materials and characterizing the drug substance itself. As development progresses toward approval, the expectations grow: manufacturers must demonstrate a thorough understanding of their process, show that critical parameters are identified and controlled, and provide evidence that the process consistently produces product within specification. This is where the QbD framework pays off, because the knowledge built during process development becomes the foundation of the regulatory case.
Key Performance Metrics
Process development teams track several core metrics to evaluate whether their work is succeeding. Yield measures how much usable product comes out relative to what went in, calculated as opportunities minus defects divided by total opportunities. Cycle time captures how long the process takes from start to finish. Throughput reflects the volume of product produced per unit of time. Purity quantifies how free the product is from unwanted contaminants.
In practice, these metrics often compete with each other. Pushing for higher purity might reduce yield. Shortening cycle time might compromise consistency. The art of process development lies in finding the combination of conditions that optimizes across all relevant metrics simultaneously, delivering a product that’s pure enough, produced fast enough, and economical enough to be commercially viable.